Skip to main
NHI

NHI Stock Forecast & Price Target

NHI Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 25%
Buy 50%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

National Health Investors is positioned for long-term growth with their focus on the senior housing market and their balanced portfolio of real estate investments and senior housing operating portfolio. Their recent $530 million acquisition will likely lead to higher growth potential and a lower leverage position, providing them with the flexibility to deploy capital in the future. Though there are short-term risks and challenges, the company's strong fundamentals and attractive dividend yield make it a favorable stock for investors seeking stable and consistent returns.

Bears say

National Health Investors is a REIT that primarily focuses on senior housing and skilled nursing facilities, which are facing challenges due to government reimbursements and oversupply in the market. The recent sale moves by NHI may help improve its debt profile, but the company is still highly leveraged and may face difficulties in the future. Additionally, NHI's exposure to its top few operators could also be a potential risk. These factors, combined with its high valuation and potential for government reimbursement disruptions, lead to a negative outlook on the company's stock.

NHI has been analyzed by 4 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 50% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of National Health Investors and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About National Health Investors (NHI) Forecast

Analysts have given NHI a Buy based on their latest research and market trends.

According to 4 analysts, NHI has a Buy consensus rating as of May 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $88.75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $88.75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

National Health Investors (NHI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.